Middle East Healthcare Co (SAU:4009) Cyclically Adjusted Revenue per Share: ﷼28.21 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4009 Middle East Healthcare Co SAU:4009
76 GF Score
Price ﷼30.72
GF Value ﷼80.60
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Middle East Healthcare Co Cyclically Adjusted Revenue per Share?

Middle East Healthcare Co SAU:4009 76 Cyclically Adjusted Revenue per Share is ﷼28.21 as of Mar. 2026. GuruFocus rates SAU:4009 with a GF Score™ of 76/100 and a GF Value™ of ﷼80.60 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Middle East Healthcare Co's adjusted revenue per share for the three months ended in Mar. 2026 was ﷼8.314. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ﷼28.21 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Middle East Healthcare Co's average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-08-17), Middle East Healthcare Co's current stock price is ﷼30.72. Middle East Healthcare Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ﷼28.21. Middle East Healthcare Co's Cyclically Adjusted PS Ratio of today is 1.09.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Middle East Healthcare Co was 3.28. The lowest was 1.05. And the median was 1.92.


Middle East Healthcare Co  (SAU:4009) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Middle East Healthcare Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=30.72/28.21
=1.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PS Ratio of Middle East Healthcare Co was 3.28. The lowest was 1.05. And the median was 1.92.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Middle East Healthcare Co Cyclically Adjusted Revenue per Share Related Terms


Middle East Healthcare Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Middle East Healthcare Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Middle East Healthcare Co Cyclically Adjusted Revenue per Share Chart

Middle East Healthcare Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 25.75 27.55

Middle East Healthcare Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.25 26.81 27.34 27.55 28.21

SAU:4009 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Middle East Healthcare Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Middle East Healthcare Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Middle East Healthcare Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Middle East Healthcare Co's Cyclically Adjusted PS Ratio falls into.


SAU:4009
76GF Score
Middle East Healthcare Co SAU:4009
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Middle East Healthcare Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Middle East Healthcare Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=8.314/330.2130*330.2130
=8.314

Current CPI (Mar. 2026) = 330.2130.

Middle East Healthcare Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.000 241.018 0.000
201609 0.000 241.428 0.000
201612 17.554 241.432 24.009
201703 4.276 243.801 5.792
201706 3.799 244.955 5.121
201709 3.808 246.819 5.095
201712 3.969 246.524 5.316
201803 4.308 249.554 5.700
201806 3.737 251.989 4.897
201809 3.697 252.439 4.836
201812 3.363 251.233 4.420
201903 3.839 254.202 4.987
201906 3.740 256.143 4.822
201909 4.202 256.759 5.404
201912 4.417 256.974 5.676
202003 4.740 258.115 6.064
202006 4.055 257.797 5.194
202009 5.347 260.280 6.784
202012 4.877 260.474 6.183
202103 4.546 264.877 5.667
202106 4.961 271.696 6.029
202109 5.419 274.310 6.523
202112 5.421 278.802 6.421
202203 5.577 287.504 6.405
202206 5.520 296.311 6.152
202209 5.567 296.808 6.194
202212 6.714 296.797 7.470
202303 6.932 301.836 7.584
202306 6.783 305.109 7.341
202309 7.291 307.789 7.822
202312 7.821 306.746 8.419
202403 7.488 312.332 7.917
202406 7.743 314.175 8.138
202409 7.954 315.301 8.330
202412 8.136 315.605 8.513
202503 7.970 319.799 8.230
202506 8.596 322.561 8.800
202509 8.355 324.800 8.494
202512 8.787 324.054 8.954
202603 8.314 330.213 8.314

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ﷼28.21 mean?
Middle East Healthcare Co (SAU:4009) has a Cyclically Adjusted Revenue per Share of ﷼28.21 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Middle East Healthcare Co and its competitors.
Is Middle East Healthcare Co's Cyclically Adjusted Revenue per Share too high?
Middle East Healthcare Co's current Cyclically Adjusted Revenue per Share is ﷼28.21. Overall, Middle East Healthcare Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Middle East Healthcare Co's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Middle East Healthcare Co's Cyclically Adjusted Revenue per Share of ﷼28.21 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Middle East Healthcare Co and its competitors. Middle East Healthcare Co's current Cyclically Adjusted Revenue per Share is ﷼28.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Middle East Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Middle East Healthcare Co (SAU:4009) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼80.60, compared to a current price of ﷼30.72 — trading 61.9% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ﷼28.21. Middle East Healthcare Co's overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Middle East Healthcare Co (SAU:4009), the current Cyclically Adjusted Revenue per Share is ﷼28.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Middle East Healthcare Co (SAU:4009) Overvalued in 2026?

Based on GuruFocus' analysis, Middle East Healthcare Co stock appears to be undervalued. The current stock price of ﷼30.72 is trading 61.9% below its estimated GF Value™ of ﷼80.60. GuruFocus considers Middle East Healthcare Co to be Possible Value Trap.

Key valuation signals for SAU:4009:

  • Cyclically Adjusted Revenue per Share: ﷼28.21
  • GF Value™: ﷼80.60 vs. price of ﷼30.72 (61.9% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the SAU:4009 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Middle East Healthcare Co Business Description

Address 4, Batterjee Road, P.O.Box 2550, Al-Zahra District, Jeddah, SAU, 21461
Middle East Healthcare Co is a Saudi Arabia-based company engaged in the business of managing, operating and maintaining hospitals, medical centers, educational centers, rehabilitation centers, physiotherapy, laboratories and radiology centers, pharmacies, construction, and to buy land for the purpose of constructing medical projects and to establish, manage and organize exhibitions for the company. The company's reportable segments are Inpatient Services, Outpatient Services, Pharmacy Sales and Others. The majority of revenue is derived from the Inpatient Services segment.
76GF Score

Get the complete analysis for SAU:4009

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼30.72
Price
﷼80.60
GF Value